Four cycles of paclitaxel and carboplatin as adjuvant treatment in early-stage ovarian cancer: a six-year experience of the Hellenic Cooperative Oncology Group

BACKGROUND: Surgery can cure a significant percentage of ovarian carcinoma confined to the pelvis. Nevertheless, there is still a 10–50% recurrence rate. We administered paclitaxel/carboplatin as adjuvant treatment in early-stage ovarian carcinoma. METHODS: Patients with stages Ia or Ib, Grade 2 or...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
मुख्य लेखकों: Bamias, Aristotle, Papadimitriou, Christos, Efstathiou, Eleni, Rodolakis, Alexandros, Vlahos, Georgios, Voulgaris, Zannis, Bozas, Georgios, Fountzilas, Georgios, Aravantinos, Gerassimos, Razis, Evagelia, Gika, Dimitra, Dimopoulos, Meletios A
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: BioMed Central 2006
विषय:
Research Article
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC1592509/
https://ncbi.nlm.nih.gov/pubmed/16999858
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-6-228
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन